Critical periods in human growth and their relationship to diseases of aging.
It has long been recognized that there are "critical periods" during mammalian development when exposure to specific environmental stimuli are required in order to elicit the normal development of particular anatomical structures or their normal functioning. The responses of the organism to these stimuli depend on a specific level of anatomical maturation and a state of rapid anatomical and/or functional change. This discussion of critical periods in growth is not confined to the classic definition of a narrow time frame of development during which a particular environmental threshold or limit must exist for normal growth and function to ensue. Using both auxological and epidemiological approaches, we suggest a lifespan perspective which encompasses accumulating and interacting risks that are manifest from prenatal life onward. By understanding the process of growth development, and by scrutinizing the growth process, early variations that lead to later disease can be identified. Here we review a significant amount of the evidence that links exposure during growth to later morbidity and mortality. The fetus appears to respond to insults during the prenatal period through the process of "programming," which has short-term survival advantages but may have a long-term disadvantage in that it is associated with cardiovascular disease, hypertension, type II diabetes, and later obesity. Low birth weight combined with rapid postnatal growth during infancy also appears to be associated, for instance, with later childhood and adult sequelae in terms of glucose tolerance and obesity. Independent of birth weight, the timing of adiposity rebound during mid-childhood also predicts later obesity. The timing, magnitude, and duration of adolescent growth and maturationare associated with critical body composition changes, including the normal acquisition of body fat and bone mineralization. In particular, the acquisition of appropriate peak bone mass is critical in determining the later risk of osteoporosis. A putative causal mechanism linking early growth variation to later chronic disease risk through telomeric attrition is discussed. The obligatory loss of telomeric DNA with each cell division serves as a mitotic clock and marks the rate of growth and repair processes in the cell. Although much more work is required, existing studies support the notion that telomere shortening is not only a clock of cellular division, but also marks relative growth rate, as well as contributing to common degenerative processes of aging through its impact on cellular senescence.
Cameron
Noël
N
Department of Human Sciences, Loughborough University, Loughborough, Leicestershire LE11 3TU, UK. N.Cameron@lboro.ac.uk
Demerath
Ellen W
EW
D000273:Adipose Tissue / Q000254:growth & development; D000293:Adolescent; D000328:Adult; D000375:Aging / Q000502:physiology*; D005075:Biological Evolution; D019521:Body Patterning / Q000502:physiology*; D015519:Bone Density / Q000502:physiology; D002318:Cardiovascular Diseases / Q000196:embryology; D002648:Child; D002657:Child Development / Q000502:physiology; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000196:embryology; D004198:Disease Susceptibility / Q000196:embryology*; D005314:Embryonic and Fetal Development / Q000502:physiology; D005260:Female; D006128:Growth / Q000502:physiology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009765:Obesity / Q000196:embryology; D011247:Pregnancy